<DOC>
	<DOCNO>NCT00651560</DOCNO>
	<brief_summary>This study intend allow physician check superior clinical efficacy Vytorin compare atorvastatin , adequate therapy use ATP-III goal achievement cardiovascular risk reduction adult patient dislipidemia .</brief_summary>
	<brief_title>Vytorin As Strategy To Reduce Dislipidemia In Adults ( 0653A-148 )</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>Patients Who Voluntary Accept To Participate In The Study After Been Informed By The Doctor And Signed The Informed Consent Form . Any Another Kind Of Contraindication For Use Of Statins Hypersensitivity To Any Of The Active Ingredients Increased Serum Hepatic Enzymes ( Over 3 Times Only ) Patients With Severe Hepatic Insufficiency Women Pregnant Potentially Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>